Business Description
Ortivus AB
SIC : 7372
ISIN : SE0000123085
Share Class Description:
OSTO:ORTI B: Class BTotal Employee Number:
34Description
Ortivus AB is a Swedish medical technology company that develops and supplies mobile solutions for emergency and prehospital care. Its MobiMed product family includes patient monitoring, electronic patient records, and fleet management systems used by ambulance services and emergency medical teams. These solutions support vital-sign monitoring, defibrillation, and secure transmission of patient data to hospitals, integrating with electronic health records, dispatch systems, and national registries. The company primarily serves healthcare providers, ambulance operators, and regional health authorities, with its main market in Sweden and additional sales in other European countries. Revenue is generated through sales and licensing of software and hardware, along with recurring support, maintenance, and service agreements. Ortivus has undergone ownership changes and restructuring in recent years, and its operations focus on the Nordic and European emergency care market.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.22 | |||||
Equity-to-Asset | 0.24 | |||||
Debt-to-Equity | 1.72 | |||||
Debt-to-EBITDA | -1.59 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.14 | |||||
Beneish M-Score | -2.22 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.4 | |||||
3-Year FCF Growth Rate | -32.2 | |||||
3-Year Book Growth Rate | -31.9 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 9 | |||||
9-Day RSI | 20.4 | |||||
14-Day RSI | 27.87 | |||||
3-1 Month Momentum % | 7.36 | |||||
6-1 Month Momentum % | 34.93 | |||||
12-1 Month Momentum % | 75.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.08 | |||||
Quick Ratio | 0.89 | |||||
Cash Ratio | 0.25 | |||||
Days Inventory | 39.83 | |||||
Days Sales Outstanding | 41.41 | |||||
Days Payable | 51.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26 | |||||
Shareholder Yield % | -1.53 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 38.27 | |||||
Operating Margin % | -25.25 | |||||
Net Margin % | -23.41 | |||||
EBITDA Margin % | -25.25 | |||||
FCF Margin % | -28.35 | |||||
OCF Margin % | -28.35 | |||||
ROE % | -391.36 | |||||
ROA % | -26.64 | |||||
ROIC % | -30.37 | |||||
3-Year ROIIC % | 860.49 | |||||
ROC (Joel Greenblatt) % | -538.23 | |||||
ROCE % | -50.29 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 1.73 | |||||
PB Ratio | 9.44 | |||||
EV-to-EBIT | -9.45 | |||||
EV-to-EBITDA | -9.45 | |||||
EV-to-Revenue | 2.38 | |||||
EV-to-FCF | -8.89 | |||||
Price-to-GF-Value | 0.89 | |||||
Price-to-Median-PS-Value | 0.73 | |||||
Earnings Yield (Greenblatt) % | -10.58 | |||||
FCF Yield % | -13.69 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ortivus AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 76.402 | ||
| EPS (TTM) (kr) | -0.272 | ||
| Beta | 1.9876 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.1 | ||
| Volatility % | 83.16 | ||
| 14-Day RSI | 27.87 | ||
| 14-Day ATR (kr) | 0.343994 | ||
| 20-Day SMA (kr) | 1.7975 | ||
| 12-1 Month Momentum % | 75.89 | ||
| 52-Week Range (kr) | 0.802 - 2.14 | ||
| Shares Outstanding (Mil) | 88.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ortivus AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ortivus AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Fourth quarter earnings results for 2026 | 2027-02-19 | In 150 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 52 days | ||
| Second quarter earnings results for 2026 | 2026-08-25 | 1.96 (+0.00%) | ||
| General meeting for 2026 | 2026-05-27 15:00 | 1.80 (-0.28%) | ||
| First quarter earnings results for 2026 | 2026-05-07 | 1.60 (+0.00%) | ||
| Annual report for 2025 | 2026-03-31 | 1.42 (+13.60%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-20 | 1.71 (-5.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-14 | 1.11 (-3.48%) | ||
| Second quarter earnings results for 2025 | 2025-08-25 | 1.20 (-1.64%) | ||
| First quarter earnings results for 2025 | 2025-05-08 08:30 | 1.38 (+0.36%) |
Show
Entries
Ortivus AB Frequently Asked Questions
What is Ortivus AB(OSTO:ORTI B)'s stock price today?
The current price of OSTO:ORTI B is kr1.53. The 52 week high of OSTO:ORTI B is kr2.14 and 52 week low is kr0.80.
When is next earnings date of Ortivus AB(OSTO:ORTI B)?
The next earnings date of Ortivus AB(OSTO:ORTI B) is 2026-11-13.
Does Ortivus AB(OSTO:ORTI B) pay dividends? If so, how much?
Ortivus AB(OSTO:ORTI B) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers